Last reviewed · How we verify
NaCl 0.3% in glucose 3.3% as maintenance fluid
NaCl 0.3% in glucose 3.3% as maintenance fluid is a Small molecule drug developed by University Hospital, Antwerp. It is currently FDA-approved.
At a glance
| Generic name | NaCl 0.3% in glucose 3.3% as maintenance fluid |
|---|---|
| Sponsor | University Hospital, Antwerp |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NaCl 0.3% in glucose 3.3% as maintenance fluid CI brief — competitive landscape report
- NaCl 0.3% in glucose 3.3% as maintenance fluid updates RSS · CI watch RSS
- University Hospital, Antwerp portfolio CI
Frequently asked questions about NaCl 0.3% in glucose 3.3% as maintenance fluid
What is NaCl 0.3% in glucose 3.3% as maintenance fluid?
NaCl 0.3% in glucose 3.3% as maintenance fluid is a Small molecule drug developed by University Hospital, Antwerp.
Who makes NaCl 0.3% in glucose 3.3% as maintenance fluid?
NaCl 0.3% in glucose 3.3% as maintenance fluid is developed and marketed by University Hospital, Antwerp (see full University Hospital, Antwerp pipeline at /company/university-hospital-antwerp).
What development phase is NaCl 0.3% in glucose 3.3% as maintenance fluid in?
NaCl 0.3% in glucose 3.3% as maintenance fluid is FDA-approved (marketed).